[ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 8
First page : ( 3957) Last page : ( 3962)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00700.3

Adjuvants employed in the fabrication of sublingual vaccines

Ananya K V*, Patil Amit B, Gowda D V, Preethi S

Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, India

*Corresponding Author E-mail: ananyakana@gmail.com

Online published on 16 September, 2020.


Throughout the world needle-free type of vaccination has become priority as it eradicates the chance of unsafe and wrong use of needles and it reduces complexity of the procedure. Many routes have been explored in the same. Mucosal route is most important among others. Mucosal routes include nasal, oral, sublingual, buccal, ocular, rectal, vaginal routes. For treating allergic hypersensitivities, sublingual mucosa has been targeted for many years. Nevertheless, sublingual vaccine delivery received little attention recently. Latest studies demonstrated the capability of sublingual vaccination to induce mucosal and systemic responses against many antigens. (Like soluble proteins, live attenuated viruses and inter particulate antigens) This review summarizes the latest discoveries that proves the sublingual vaccine delivery is potential to provide protection against several mucosal pathogens.



Vaccines, Adjuvants, Sublingual vaccine, Immunity, Mucosal route.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
777,158,976 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.